Bayer CropScience Limited

NSE:BAYERCROP.NS

6433.55 (INR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Revenue 51,39751,39745,76741,42835,19026,02126,11127,17836,44136,15331,46226,26022,04420,386.84116,247.61913,940.04911,633.5177,278.4517,278.4517,230.798,488.005
Cost of Revenue 28,16028,16026,77424,58519,22014,87316,01616,46724,88824,15420,91817,46214,57213,741.48310,482.9549,369.377,662.4674,527.2334,527.2333,788.3544,324.857
Gross Profit 23,23723,23718,99316,84315,97011,14810,09510,71111,55311,99910,5448,7987,4726,645.3585,764.6654,570.6793,971.052,751.2182,751.2183,442.4364,163.148
Gross Profit Ratio 0.4520.4520.4150.4070.4540.4280.3870.3940.3170.3320.3350.3350.3390.3260.3550.3280.3410.3780.3780.4760.49
Reseach & Development Expenses 685831749558543577205204181222202158000000000
General & Administrative Expenses 2,9311,2901,0301,1191,10587271770366359859655043001,249.1611,200.3981,407.1511,002.6561,002.0321,377.9461,097.062
Selling & Marketing Expenses 2,4124,2154,2952,9932,8042,6122,1722,1182,3782,2372,2671,8771,71901,450.4081,360.3531,023.068575.224577.831996.211,078.547
SG&A 5,3435,5055,3254,1123,9093,4842,8892,8213,0412,8352,8632,4272,14902,699.5692,560.7512,430.2191,577.881,579.8632,374.1562,175.609
Other Expenses 81014,7906,0655,2945,3774,0653,3208187886461875,535.911,126.615964.312889.657474.062482.365820.1891,067.32
Operating Expenses 14,79014,79011,3909,4069,2867,5496,2096,6697,4686,9276,8595,3865,1245,535.913,826.1843,525.0633,319.8762,051.9422,062.2283,194.3453,242.929
Operating Income 8,4479,0867,9947,8577,1973,8874,1494,5514,7015,8094,4433,9182,5962,115.3192,191.0061,712.35881.5811,048.3361,048.336692.18980.64
Operating Income Ratio 0.1640.1770.1750.190.2050.1490.1590.1670.1290.1610.1410.1490.1180.1040.1350.1230.0760.1440.1440.0960.116
Total Other Income Expenses Net 1,45481547488-1,366-224-111-72-72-74-3511,714-552-125.66-226.559-204.083-202.018-157.805-157.805-168.145-508.604
Income Before Tax 9,9019,9018,4687,9455,8313,6634,0384,4794,6295,7354,40815,6322,0441,989.6591,964.4471,508.267679.563890.531890.531524.035472.036
Income Before Tax Ratio 0.1930.1930.1850.1920.1660.1410.1550.1650.1270.1590.140.5950.0930.0980.1210.1080.0580.1220.1220.0720.056
Income Tax Expense 2,3192,3192,0153,0141,0861,2871,0371,5691,6201,9051,5134,015654674.218691.912563.672188.538321.953321.953260.431119.472
Net Income 7,4057,5826,4534,9314,7452,3763,0012,9103,0093,8302,89511,6171,3901,315.4411,272.535944.595491.025568.578568.578263.604352.564
Net Income Ratio 0.1440.1480.1410.1190.1350.0910.1150.1070.0830.1060.0920.4420.0630.0650.0780.0680.0420.0780.0780.0360.042
EPS 168.71168.71143.58109.72105.5855.386.1682.3187.34104.5975.14294.1135.1933.332.2223.9112.4314.3914.396.6711.74
EPS Diluted 168.71168.71143.58109.72105.5855.386.1682.3187.34104.5975.14294.1135.1933.332.2223.9112.4314.3914.396.6711.74
EBITDA 9,6959,8818,6398,5927,8504,2294,4804,8404,9486,0625,0894,3803,0462,442.2112,455.4251,952.2711,142.8041,266.9731,266.973952.3611,276.131
EBITDA Ratio 0.1890.1920.1890.2070.2230.1630.1720.1780.1360.1680.1620.1670.1380.120.1510.140.0980.1740.1740.1320.15